CO5650245A2 - Formulaciones dispersable de un agente anti-inflamatorio - Google Patents
Formulaciones dispersable de un agente anti-inflamatorioInfo
- Publication number
- CO5650245A2 CO5650245A2 CO05130971A CO05130971A CO5650245A2 CO 5650245 A2 CO5650245 A2 CO 5650245A2 CO 05130971 A CO05130971 A CO 05130971A CO 05130971 A CO05130971 A CO 05130971A CO 5650245 A2 CO5650245 A2 CO 5650245A2
- Authority
- CO
- Colombia
- Prior art keywords
- agent
- inflammatory agent
- organ
- inflammatory
- agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Oncology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49212103P | 2003-07-31 | 2003-07-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO5650245A2 true CO5650245A2 (es) | 2006-06-30 |
Family
ID=34103027
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO05130971A CO5650245A2 (es) | 2003-07-31 | 2005-12-29 | Formulaciones dispersable de un agente anti-inflamatorio |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP1651210A1 (ja) |
| JP (1) | JP2007500691A (ja) |
| KR (1) | KR100780983B1 (ja) |
| CN (1) | CN1829510A (ja) |
| AU (1) | AU2004258745A1 (ja) |
| BR (1) | BRPI0412581A (ja) |
| CA (1) | CA2533101A1 (ja) |
| CO (1) | CO5650245A2 (ja) |
| IL (1) | IL172735A0 (ja) |
| MX (1) | MXPA06001288A (ja) |
| NO (1) | NO20060982L (ja) |
| RU (1) | RU2319508C2 (ja) |
| WO (1) | WO2005009436A1 (ja) |
| ZA (1) | ZA200600096B (ja) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20081406A1 (es) * | 2006-12-20 | 2008-10-17 | Schering Plough Ltd | Composiciones farmaceuticas de flunixina |
| GB0711776D0 (en) * | 2007-06-18 | 2007-07-25 | Syngenta Participations Ag | Substituted aromatic heterocyclic compounds as fungicides |
| UA111147C2 (uk) * | 2009-11-11 | 2016-04-11 | Байєр Б.В. | Способи та композиції для лікування або профілактики зовнішнього отиту |
| GB2477590A (en) * | 2010-02-05 | 2011-08-10 | Biocopea Ltd | A non-steroidal anti-inflammatory drug (NSAID) formulation comprising a lipid carrier |
| EP2366408B1 (en) * | 2010-03-01 | 2012-07-18 | Laboratorios SALVAT, S.A. | Aqueous clear solutions of fluocinolone acetonide for treatment of otic inflammation |
| US8895536B2 (en) | 2010-10-29 | 2014-11-25 | Infirst Healthcare Ltd. | Compositions and methods for treating chronic inflammation and inflammatory diseases |
| US10695431B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US11202831B2 (en) | 2010-10-29 | 2021-12-21 | Infirst Healthcare Limited | Solid solution compositions and use in cardiovascular disease |
| US10695432B2 (en) | 2010-10-29 | 2020-06-30 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9504664B2 (en) | 2010-10-29 | 2016-11-29 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9737500B2 (en) | 2010-10-29 | 2017-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9744132B2 (en) | 2010-10-29 | 2017-08-29 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| US11224659B2 (en) | 2010-10-29 | 2022-01-18 | Infirst Healthcare Limited | Solid solution compositions and use in severe pain |
| US9271950B2 (en) | 2010-10-29 | 2016-03-01 | Infirst Healthcare Limited | Compositions for treating chronic inflammation and inflammatory diseases |
| US11730709B2 (en) | 2010-10-29 | 2023-08-22 | Infirst Healthcare Limited | Compositions and methods for treating severe pain |
| US9308213B2 (en) | 2010-10-29 | 2016-04-12 | Infirst Healthcare Limited | Solid solution compositions and use in chronic inflammation |
| RU2486905C1 (ru) * | 2012-05-28 | 2013-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный технологический университет" (ФГБОУ ВПО "КубГТУ") | Средство для лечения мастита у животных |
| CN102784161A (zh) * | 2012-08-01 | 2012-11-21 | 张吉川 | 一种治疗急慢性中耳炎的特效滴耳液 |
| BR112015015858B1 (pt) * | 2013-01-14 | 2023-02-28 | Infirst Healthcare Limited | Uso de uma composição farmacêutica de solução sólida no tratamento de uma inflamação crônica |
| WO2014117999A1 (en) * | 2013-02-04 | 2014-08-07 | Biocopea Limited | Compositions and methods for treating chronic inflammation and inflammatory diseases |
| LV15071B (lv) * | 2015-07-14 | 2016-02-20 | Rīgas Stradiņa Universitāte | Kompozīcija subklīniska mastīta ārstēšanai govīm |
| KR20180030416A (ko) * | 2015-08-05 | 2018-03-22 | 칠드런'즈 메디컬 센터 코포레이션 | 약물 전달을 위한 침투 증강제를 수반한 조성물 |
| US10561684B2 (en) | 2015-08-27 | 2020-02-18 | Min Bo SHIM | Pharmaceutical composition for preventing or treating sensorineural hearing loss or tinnitus including platelet-rich plasma and method using the same |
| KR101738815B1 (ko) * | 2015-08-27 | 2017-05-23 | 심민보 | 혈소판 풍부 혈장을 포함하는 감각신경성 난청 또는 이명을 예방 또는 치료하기 위한 약학적 조성물 및 이를 이용한 방법 |
| WO2019191547A1 (en) * | 2018-03-29 | 2019-10-03 | Yale University | Novel fully synthetic and semisynthetic pleuromutilin derivatives as new antibiotics and their preparation |
| RU2749857C1 (ru) * | 2019-12-23 | 2021-06-17 | Псарева Нелли Александровна | Способ борьбы со средним и наружным отитом |
| RU2751697C1 (ru) * | 2020-09-09 | 2021-07-15 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Донской государственный аграрный университет" | Средство для лечения отитов наружного слухового прохода у собак |
| KR102461699B1 (ko) * | 2021-05-21 | 2022-11-03 | 현대약품 주식회사 | 벤지다민염산염을 포함하는 안정성이 개선된 가글액 |
| WO2023101421A1 (ko) * | 2021-12-03 | 2023-06-08 | (주)인비보텍 | 난청 또는 이명의 예방 또는 치료용 조성물 |
| WO2023101418A1 (ko) * | 2021-12-03 | 2023-06-08 | (주)인비보텍 | 난청 또는 이명의 예방 또는 치료용 조성물 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5314685A (en) * | 1992-05-11 | 1994-05-24 | Agouron Pharmaceuticals, Inc. | Anhydrous formulations for administering lipophilic agents |
| GB2308546B (en) * | 1994-10-26 | 1999-06-02 | Novartis Ag | Topical macrolide compositions |
| ES2173287T3 (es) * | 1995-06-06 | 2002-10-16 | Bayer Ag | Composiciones oticas antibacterianas no irritantes, no sensibilizantes y no ototoxicas. |
| DZ2479A1 (fr) * | 1997-05-05 | 2003-02-01 | Pfizer | Composés inhibiteurs sélectifs de cox-2 anti-inflammatoires et compositions pharmaceutiques les contenant. |
| US6440964B1 (en) * | 1998-09-30 | 2002-08-27 | Alcon Manufacturing, Ltd. | Compositions and methods for treating ophthalmic and otic infections |
| CN1617716A (zh) * | 2000-06-08 | 2005-05-18 | 德克萨斯系统大学评议会 | 杂环衍生物与使用方法 |
| AU2001268512A1 (en) * | 2000-06-16 | 2002-01-02 | Hercules Incorporated | Chemically-modified peptides, compositions, and methods of production and use |
| US20040033938A1 (en) * | 2000-09-12 | 2004-02-19 | Britten Nancy J. | Cyclooxygenase-2 inhibitor and antibacterial agent combination for intramammary treatment of mastitis |
| EP1317252A2 (en) * | 2000-09-12 | 2003-06-11 | PHARMACIA & UPJOHN COMPANY | Pharmaceutical composition having specific water activity |
| TW200403072A (en) * | 2002-01-23 | 2004-03-01 | Upjohn Co | Combination therapy for the treatment of bacterial infections |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
-
2004
- 2004-07-19 AU AU2004258745A patent/AU2004258745A1/en not_active Abandoned
- 2004-07-19 MX MXPA06001288A patent/MXPA06001288A/es not_active Application Discontinuation
- 2004-07-19 JP JP2006521702A patent/JP2007500691A/ja not_active Withdrawn
- 2004-07-19 WO PCT/IB2004/002461 patent/WO2005009436A1/en active Application Filing
- 2004-07-19 RU RU2006101628/14A patent/RU2319508C2/ru not_active IP Right Cessation
- 2004-07-19 EP EP04744112A patent/EP1651210A1/en not_active Withdrawn
- 2004-07-19 KR KR1020067002034A patent/KR100780983B1/ko not_active IP Right Cessation
- 2004-07-19 CA CA002533101A patent/CA2533101A1/en not_active Abandoned
- 2004-07-19 BR BRPI0412581-9A patent/BRPI0412581A/pt not_active IP Right Cessation
- 2004-07-19 CN CNA200480022099XA patent/CN1829510A/zh active Pending
-
2005
- 2005-12-21 IL IL172735A patent/IL172735A0/en unknown
- 2005-12-29 CO CO05130971A patent/CO5650245A2/es not_active Application Discontinuation
-
2006
- 2006-01-03 ZA ZA200600096A patent/ZA200600096B/en unknown
- 2006-02-28 NO NO20060982A patent/NO20060982L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100780983B1 (ko) | 2007-11-30 |
| IL172735A0 (en) | 2006-04-10 |
| WO2005009436A8 (en) | 2005-05-06 |
| AU2004258745A1 (en) | 2005-02-03 |
| CA2533101A1 (en) | 2005-02-03 |
| CN1829510A (zh) | 2006-09-06 |
| MXPA06001288A (es) | 2006-04-11 |
| WO2005009436A1 (en) | 2005-02-03 |
| RU2319508C2 (ru) | 2008-03-20 |
| BRPI0412581A (pt) | 2006-09-19 |
| KR20060031873A (ko) | 2006-04-13 |
| JP2007500691A (ja) | 2007-01-18 |
| NO20060982L (no) | 2006-05-02 |
| RU2006101628A (ru) | 2006-08-27 |
| EP1651210A1 (en) | 2006-05-03 |
| ZA200600096B (en) | 2007-02-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO5650245A2 (es) | Formulaciones dispersable de un agente anti-inflamatorio | |
| UY28236A1 (es) | Composicion farmaceutica dispersable para el tratamiento de mastitis y trastornos oticos. | |
| CO5611169A2 (es) | Formulacion dispersable de un agente antiinflamatorio | |
| AR042537A1 (es) | Composiciones farmaceuticas dispersables que contienen antibacterianos para animales productores de leche | |
| AR037255A1 (es) | Composiciones farmaceuticas que contienen oxibutinina | |
| US5260073A (en) | Use of phenylpropanolamine as a mucus secretogogue in the upper airways | |
| ES2213139T5 (es) | Tratamiento de trastornos intestinales no inflamatorios. | |
| CO4970819A1 (es) | Tratamiento de disfuncion sexual femenina en una hembra humana | |
| AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
| RU2560879C2 (ru) | Cпособ профилактики передающихся половым путем вирусных заболеваний, лекарственное средство, способ получения лекарственного средства, фармацевтическая композиция для местного применения и презерватив | |
| ES2236180T3 (es) | Composiciones oftalmicas antialergicas adecuadas para uso con lentes de contacto. | |
| AR002049A1 (es) | Una composicion farmaceutica para la administracion oral de agentes activos que tienen baja solubilidad en agua y el procedimiento para prepararla | |
| EP0530311A1 (en) | The use of phenylpropanolamine as a mucus secretagogue in the upper airways | |
| AR041069A1 (es) | Composicion de tolterodina liquida oral | |
| AR022338A1 (es) | Un compuesto de benzamida, medicamento que lo contiene, y uso para la manufactura de un medicamento para el tratamiento o prevencion de una enfermedad digestiva o para mejorar la movilidad del tracto gastrointestinal. | |
| DE60331920D1 (de) | Orale pharmazeutische zusammensetzung für weichkapseln mit vinorelbin und behandlungsverfahren | |
| AR022348A1 (es) | Una composicion farmaceutica para el tratamiento de los sintomas del tracto urinario inferior | |
| RU2002110952A (ru) | Крем "Брамизил" противогрибкового действия | |
| JP2005075735A (ja) | オキシメタゾリン含有組成物 | |
| JP2023120462A (ja) | 医薬組成物 | |
| JP6154718B2 (ja) | 下部尿路疾患治療剤 | |
| ES2172818T3 (es) | Uso de antagonistas de lh-rh como agente de diagnostico. | |
| JP5217530B2 (ja) | 坐剤 | |
| PE20040204A1 (es) | Administracion de agentes para el tratamiento de la inflamacion | |
| JP2007145829A (ja) | イブプロフェンを含有する医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Application refused |